Q32 Bio Inc. (QTTB)
NASDAQ
16.32
-0.04 (-0.24%)
Closed
Aug 25, 2026
Day's Range
16.0616.98
52 wk Range
1.6223.57
Financial Statements - QTTB - Q32 Bio Inc.
Revenue
53.73M
Net Income
29.82M▲ 162.5%Net Margin 55.5%
EBITDA
19.57M▲ 132.8%
Free Cash Flow
-33.54M▲ 50.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Sales | 53.73M | 0 | - | 6.65M | 0 |
| Cost of Goods | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
 Operating Expense | - | - | - | - | - |
| Operating Income | 16.90M | -66.10M | - | -39.22M | -36.69M |
| Non-Operating Interest | - | - | - | - | - |
| Other Income Expense | 11.81M | 17.21M | - | -3.52M | -324K |
| Pre Tax Income | 29.82M | -46.08M | - | -42.74M | -37.01M |
| Income Tax | 0 | 21K | - | 62K | 547K |
| Net Income | 29.82M | -47.73M | - | -42.80M | -37.56M |
| EPS Basic | 2.42 | -5.12 | -4.50504 | -3.588491 | -3.148825 |
| EPS Diluted | 2.42 | -6.58 | -4.50504 | -3.588491 | -3.148825 |
| Basic Shares Outstanding | 12.30M | 9.32M | 11.92M | 11.92M | 11.92M |
| Diluted Shares Outstanding | 12.30M | 9.32M | 11.92M | 11.92M | 11.92M |
| Ebit | 30.92M | -44.98M | - | -39.22M | -36.69M |
| Ebitda | 19.57M | -59.69M | - | -36.45M | -36.64M |
| Net Income Continuous Operations | 29.82M | -47.73M | - | -42.80M | -37.56M |
| Minority Interests | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
